Peña DMA

Language: Spanish
References: 7
Page: 109-111
PDF size: 41.55 Kb.

ABSTRACT

Angiogenesis is a novel treatment for patients with advanced ischemic heart disease and poor candidates for conventional revascularization treatment as angioplasty or surgery. It is based on the formation of new blood vessels in response to growth factors.

REFERENCES

1. Carmeliet P: Mechanism of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.

2. Simons M, Bonow R, Chronos N, Cohen DJ, Giordano FJ, Hammond K, Laham RJ, et al: Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus An Expert Panel Summary. Circulation 2000; 102: e73-e86.

3. Gibson CM, Ryan K, Sparano A: Angiographic methods to assess human coronary angiogenesis. Am Heart J 1999; 137: 169-179.

4. Ito W, Arras M, Scholz D: Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 1997; 272: H1255-H1265.

5. Schultz A, Lavie L, Hochberg I: Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999; 100: 547-552.

6. Rivard A, Fabre JE, Silver M: Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-120.

7. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, et al: Pharmacological Treatment of Coronary Artery Disease with Recombinant Fibroblast Growth Factor-2. Circulation 2002; 105: 788-793.